562 related articles for article (PubMed ID: 28362108)
1. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
[TBL] [Abstract][Full Text] [Related]
2. Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency.
Campbell EJ; Campbell MA; Boukedes SS; Owen CA
J Clin Invest; 1999 Aug; 104(3):337-44. PubMed ID: 10430615
[TBL] [Abstract][Full Text] [Related]
3. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency.
Belchamber KBR; Walker EM; Stockley RA; Sapey E
Int J Chron Obstruct Pulmon Dis; 2020; 15():3183-3192. PubMed ID: 33311976
[TBL] [Abstract][Full Text] [Related]
4. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
Abboud RT; Ford GT; Chapman KR
Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
[TBL] [Abstract][Full Text] [Related]
5. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
[TBL] [Abstract][Full Text] [Related]
6. Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency.
Carroll TP; Greene CM; O'Connor CA; Nolan AM; O'Neill SJ; McElvaney NG
J Immunol; 2010 Apr; 184(8):4538-46. PubMed ID: 20228200
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.
Moreno JA; Ortega-Gomez A; Rubio-Navarro A; Louedec L; Ho-Tin-Noé B; Caligiuri G; Nicoletti A; Levoye A; Plantier L; Meilhac O
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):536-49. PubMed ID: 24787644
[TBL] [Abstract][Full Text] [Related]
10. Aberrant disulphide bonding contributes to the ER retention of alpha1-antitrypsin deficiency variants.
Ronzoni R; Berardelli R; Medicina D; Sitia R; Gooptu B; Fra AM
Hum Mol Genet; 2016 Feb; 25(4):642-50. PubMed ID: 26647313
[TBL] [Abstract][Full Text] [Related]
11. Increased outer arm and core fucose residues on the N-glycans of mutated alpha-1 antitrypsin protein from alpha-1 antitrypsin deficient individuals.
McCarthy C; Saldova R; O'Brien ME; Bergin DA; Carroll TP; Keenan J; Meleady P; Henry M; Clynes M; Rudd PM; Reeves EP; McElvaney NG
J Proteome Res; 2014 Feb; 13(2):596-605. PubMed ID: 24328305
[TBL] [Abstract][Full Text] [Related]
12. The discovery of α1-antitrypsin and its role in health and disease.
Janciauskiene SM; Bals R; Koczulla R; Vogelmeier C; Köhnlein T; Welte T
Respir Med; 2011 Aug; 105(8):1129-39. PubMed ID: 21367592
[TBL] [Abstract][Full Text] [Related]
13. Novel variants of SERPIN1A gene: Interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease.
Bashir A; Shah NN; Hazari YM; Habib M; Bashir S; Hilal N; Banday M; Asrafuzzaman S; Fazili KM
Respir Med; 2016 Aug; 117():139-49. PubMed ID: 27492524
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
[TBL] [Abstract][Full Text] [Related]
16. The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency.
Pini L; Tiberio L; Venkatesan N; Bezzi M; Corda L; Luisetti M; Ferrarotti I; Malerba M; Lomas DA; Janciauskiene S; Vizzardi E; Modina D; Schiaffonati L; Tantucci C
Respir Res; 2014 Sep; 15(1):112. PubMed ID: 25218041
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils.
Lee J; Lu Y; Oshins R; West J; Moneypenny CG; Han K; Brantly ML
Front Immunol; 2020; 11():574410. PubMed ID: 33329539
[TBL] [Abstract][Full Text] [Related]
18. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
Zuo L; Pannell BK; Zhou T; Chuang CC
Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
[TBL] [Abstract][Full Text] [Related]
19. [From gene disease; alpha1-antitrypsine deficiency].
Hiemstra PS; Stolk J
Ned Tijdschr Geneeskd; 2003 Apr; 147(16):758-60. PubMed ID: 12731467
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets alpha1-antitrypsin serpin.
Li W; Savinov AY; Rozanov DV; Golubkov VS; Hedayat H; Postnova TI; Golubkova NV; Linli Y; Krajewski S; Strongin AY
Cancer Res; 2004 Dec; 64(23):8657-65. PubMed ID: 15574774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
